Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr. Reddy's Lab - Quaterly Results

Date: 25-01-2023
The Revenue for the quarter ended  December 2022 of Rs. 38976.00 millions grew by 12.01 % from Rs. 34796.00 millions.The Net Profit of the company registered a slight decline of -4.84% to Rs. 3246.00  millions from Rs. 3411.00 millions.Operating Profit saw a handsome growth to 7265.00 millions from 6770.00 millions in the quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 38976.00 34796.00 12.01 124085.00 107365.00 15.57 144052.00 133491.00 7.91
Other Income 514.00 630.00 -18.41 5728.00 3673.00 55.95 4820.00 8011.00 -39.83
PBIDT 7265.00 6770.00 7.31 36302.00 22915.00 58.42 30761.00 39379.00 -21.88
Interest 28.00 77.00 -63.64 143.00 253.00 -43.48 380.00 467.00 -18.63
PBDT 7237.00 6693.00 8.13 36159.00 22662.00 59.56 30381.00 38912.00 -21.92
Depreciation 2388.00 2054.00 16.26 6865.00 6091.00 12.71 8143.00 8350.00 -2.48
PBT 4849.00 4639.00 4.53 29294.00 16571.00 76.78 22238.00 30562.00 -27.24
TAX 1603.00 1228.00 30.54 9890.00 4536.00 118.03 6006.00 8698.00 -30.95
Deferred Tax -385.00 416.00 -192.55 3568.00 1584.00 125.25 2080.00 3297.00 -36.91
PAT 3246.00 3411.00 -4.84 19404.00 12035.00 61.23 16232.00 21864.00 -25.76
Equity 833.00 832.00 0.12 833.00 832.00 0.12 832.00 832.00 0.00
PBIDTM(%) 18.64 19.46 -4.20 29.26 21.34 37.07 21.35 29.50 -27.61